ISO 11607 is the international standard governing sterile barrier system packaging for medical devices. If your device reaches the patient in a sterile state, this standard applies. It defines the requirements your packaging materials must meet, the validation testing you need to perform, and the documentation your quality system must maintain.

    The standard is recognized by the FDA, the European Commission under the Medical Device Regulation (MDR), and regulatory bodies in most major markets. Non-compliance creates submission risk, audit findings, and in the worst case, a packaging failure that puts patient safety and your product recall history in the same sentence.

    This guide covers what ISO 11607 requires, how the two parts of the standard work together, and what manufacturers need to do to demonstrate compliance during a regulatory audit.

    What Is ISO 11607 and Who Needs to Comply?

    ISO 11607 specifies requirements for materials, preformed sterile barrier systems, sterile barrier systems, and packaging systems intended to maintain sterility of terminally sterilized medical devices up to the point of use. The standard is published by the International Organization for Standardization and is harmonized with both FDA regulations and European MDR requirements.

    If your product is a terminally sterilized medical device, meaning it is sterilized in its final packaging configuration, ISO 11607 applies. This covers the vast majority of single-use devices: surgical instruments, implantables, diagnostic kits, wound care products, catheter systems, and anything else that must arrive at the point of use in a confirmed sterile state.

    Contract manufacturers, packaging converters, and device manufacturers all operate within the scope of the standard, though their specific obligations differ. The device manufacturer bears responsibility for the overall sterile barrier system and its validation. Converters like Technipaq operate within a quality system (ISO 13485) that supports the manufacturer’s compliance obligations.

    What Each Part of ISO 11607 Requires

    ISO 11607 is divided into two parts. They address different aspects of sterile packaging compliance and must both be satisfied for a complete, defensible compliance posture.

    ISO 11607-1: Materials, Preformed Sterile Barrier Systems, and Sterile Barrier Systems

    Part 1 covers the materials and design requirements for the packaging system itself. It defines what the sterile barrier system must do and what properties it must demonstrate.

    The key requirements under ISO 11607-1 include:

    • Biocompatibility: Packaging materials must not adversely affect the safety or performance of the device. Materials in contact with the device or sterilant must meet biocompatibility requirements consistent with ISO 10993.
    • Microbial Barrier: The sterile barrier system must prevent microbial penetration throughout the intended shelf life. This is the primary performance requirement. For porous materials like Tyvek, microbial barrier is characterized through porosity testing and validated against standardized challenge tests.
    • Physical and Chemical Properties: Materials must maintain their performance characteristics through sterilization, storage, and distribution. This includes properties like seal strength, tensile strength, tear resistance, and resistance to environmental conditions.
    • Compatibility with Sterilization: Packaging materials must be compatible with the intended sterilization method. The standard requires that sterilization does not compromise the integrity or performance of the sterile barrier system.
    • Cleanliness: Materials must not introduce contamination. Particulate generation during opening is specifically relevant here, which is why clean-peel performance is a functional requirement rather than a cosmetic one.

    ISO 11607-2: Validation Requirements for Forming, Sealing, and Assembly Processes

    Part 2 covers the validation of the processes used to form, seal, and assemble the sterile barrier system. Where Part 1 defines what the packaging must achieve, Part 2 defines how you prove that the process reliably produces compliant packaging.

    The validation framework under ISO 11607-2 follows the standard IQ/OQ/PQ structure:

    • Installation Qualification (IQ): Documents that equipment is installed correctly and meets manufacturer specifications. For packaging, this includes sealing equipment, laminating lines, and any forming equipment.
    • Operational Qualification (OQ): Establishes the operating parameters that produce acceptable packaging. For sealing processes, this means defining and testing the temperature, pressure, and dwell time ranges that produce seals meeting the acceptance criteria.
    • Performance Qualification (PQ): Demonstrates that the process consistently produces compliant packaging under actual production conditions. PQ testing uses production materials, production equipment, and production personnel.

    Part 2 also requires that any change to the process, materials, or equipment that could affect package integrity be evaluated and re-validated as appropriate. This is the source of many audit findings, because teams often change a supplier or a material grade without triggering a formal change control evaluation.

    ISO 11607 At a Glance

    Standard Part Scope Key Requirements
    ISO 11607-1 Materials and design Microbial barrier, biocompatibility, physical properties, sterilization compatibility, cleanliness
    ISO 11607-2 Process validation IQ/OQ/PQ for forming, sealing, and assembly; change control; ongoing process monitoring

    Sterile Barrier System vs. Protective Packaging: Understanding the Definitions

    ISO 11607 draws a clear line between two distinct functions within a medical device packaging configuration.

    The sterile barrier system is the minimum packaging necessary to prevent the entry of microorganisms and allow aseptic presentation of the sterile contents at the point of use. This is the functional barrier, the pouches, trays, lids, or wraps that directly contain the device and maintain sterility. For most single-use devices, the sterile barrier system is the pouch itself.

    Protective packaging is everything that surrounds the sterile barrier system to protect it during distribution. Cartons, shipping boxes, cushioning materials, and secondary pouches all fall under protective packaging. Protective packaging does not have to meet the microbial barrier requirements of the sterile barrier system, but it must protect the sterile barrier system from damage that could compromise integrity.

    The distinction matters in documentation. Your design history file and technical file need to clearly identify which components constitute the sterile barrier system and validate those specifically. Auditors look for this separation, and conflating the two functions creates documentation gaps that require explanation.

    Working through ISO 11607 packaging compliance for a new device?

    Technipaq partners with medical device manufacturers at the specification, prototyping, and validation stages to deliver packaging that meets ISO 11607 requirements. Contact the team at technipaq.com to discuss your sterile barrier system requirements.

    How to Validate Packaging to ISO 11607

    Packaging validation under ISO 11607-2 is not a single test, it is a structured program that covers process qualification, package integrity testing, and accelerated aging. The scope of validation depends on the device, the sterilization method, the packaging format, and the distribution conditions the packaging must survive.

    Package Integrity Testing

    Package integrity testing demonstrates that the sterile barrier system maintains its barrier properties under the stresses of sterilization and distribution. The primary tests specified or referenced under ISO 11607 include:

    • Seal strength testing (ASTM F88): Measures the force required to peel the seal. Acceptance criteria are established during OQ based on testing across the defined sealing parameter range.
    • Burst testing (ASTM F1140 / F2054): Applies internal pressure to the package until failure. Identifies weak seals, material failures, and seal consistency issues across the package perimeter.
    • Dye penetration testing (ASTM F1929): Applies colored dye to the seal area and evaluates penetration as an indicator of seal channel defects. Used for porous/non-porous package combinations.
    • Microbial challenge testing: Evaluates the microbial barrier of the packaging material itself. Typically performed as part of material qualification rather than lot release testing.

    Accelerated Aging and Real-Time Aging

    ISO 11607 requires that packaging be validated for the intended shelf life of the device. Accelerated aging uses elevated temperature conditions to simulate the passage of time, following ASTM F1980 protocols. The accelerated aging study must be supported by a real-time aging study running concurrently, because accelerated aging alone is not considered sufficient justification for a shelf life claim.

    Shelf life validation is one of the most time-consuming elements of packaging validation. Teams that start this process late in device development often find themselves holding a cleared device that cannot ship because packaging aging studies are still running. Building packaging validation into the development timeline early avoids this.

    Distribution Simulation

    The sterile barrier system must maintain integrity through the distribution conditions the device will actually face, not just laboratory conditions. ASTM D4169 and ISTA protocols define standardized test sequences that simulate the vibration, shock, compression, and environmental conditions of common distribution scenarios. Packaging validation must demonstrate that the sterile barrier system survives the applicable distribution cycle with integrity intact.

    Documentation and Quality System Requirements

    ISO 11607 compliance is not just about testing. It is about maintaining the documentation that proves you performed the testing correctly, under controlled conditions, with traceable records. Regulatory auditors are as likely to ask for your documentation as they are to ask about your test results.

    The documentation requirements that support ISO 11607 compliance include:

    • Design history file (DHF): Documents the packaging design process, including material selection rationale, design inputs and outputs, design verification and validation data, and design reviews.
    • Validation protocols and reports: Formal documents that define the acceptance criteria before testing begins (protocol) and record the results and conclusions after testing is complete (report). Acceptance criteria cannot be defined after seeing the data.
    • Material specifications and certificates of conformance: Documentation that the materials used in production match the materials used in validation. Supplier changes require evaluation under your change control procedure.
    • Process control records: Evidence that sealing and forming processes were operated within validated parameters during production. For sealing equipment, this typically means monitoring temperature, pressure, and dwell time for each lot.
    • Change control records: Documentation of any changes to materials, equipment, processes, or suppliers, and the evaluation of whether those changes require re-validation.

    Demonstrating Compliance During Regulatory Audits

    Packaging is a consistent focus area in FDA inspections and notified body audits under MDR. Auditors know that packaging failures are a leading cause of recalls and they look for specific evidence that the sterile barrier system was properly designed, validated, and controlled.

    The most common packaging-related audit findings involve:

    • Missing or incomplete validation: Sealing process validation that lacks OQ or PQ data, or that was never performed for a change made after initial validation.
    • Acceptance criteria defined after data collection: Protocols that do not define acceptance criteria before testing begins, or data-driven acceptance criteria that were adjusted based on results.
    • Inadequate change control: Material or supplier changes that were not evaluated for their potential impact on package integrity, particularly substitutions made during supply disruptions.
    • Shelf life claims without aging data: Labeled shelf life that exceeds what the aging studies actually support, or real-time aging studies that were discontinued before the labeled expiration date.
    • Poor traceability: Inability to link specific production lots of packaging to the validated parameters under which they were produced.

    Working with a converter that operates under ISO 13485 and maintains robust quality records reduces the traceability burden on the device manufacturer. Technipaq’s quality system covers material receipt and incoming inspection, process monitoring during production, and traceability documentation that supports the device manufacturer’s compliance file.

    How Barrier Pouches Meet ISO 11607 Requirements

    Barrier pouches, including Tyvek/film combinations and foil laminate structures, are among the most common sterile barrier systems used in medical device packaging. Their compliance with ISO 11607-1 depends on the specific materials specified and the sealing process parameters established during validation.

    Porous materials like Tyvek meet the microbial barrier requirement through the material’s nonwoven structure, which blocks bacterial spores while allowing sterilizing gases to penetrate. The microbial barrier of Tyvek is extensively characterized in published literature and DuPont’s technical documentation, which simplifies the material qualification process for manufacturers.

    Non-porous materials like foil laminates and clear films provide a different kind of barrier, complete impermeability to gases, moisture, and microorganisms. These materials are used with non-gas sterilization methods or when the sterilization port is the Tyvek component of a combination pouch. Seal integrity is the critical performance variable for non-porous pouches, because the seal is the only location where the barrier can be compromised without visible damage.

    Technipaq’s peelable pouch designs are produced under ISO 13485 with documented sealing processes, incoming material inspection, and in-house seal strength, porosity, and burst testing. The company’s laboratory capabilities support the validation testing manufacturers need to complete their ISO 11607-2 compliance programs.

    Frequently Asked Questions

    What is ISO 11607 and who needs to comply?

    ISO 11607 is the international standard for sterile barrier system packaging for terminally sterilized medical devices. Any manufacturer whose device is sterilized in its final packaging configuration and reaches the patient in a sterile state must comply. The standard is recognized by the FDA, the European Commission under MDR, and most other major regulatory jurisdictions.

    What is the difference between ISO 11607-1 and ISO 11607-2?

    ISO 11607-1 covers the requirements for packaging materials and sterile barrier system design, including microbial barrier, biocompatibility, physical properties, and sterilization compatibility. ISO 11607-2 covers the validation requirements for the processes used to form, seal, and assemble the sterile barrier system, following an IQ/OQ/PQ framework.

    How do you validate packaging to ISO 11607?

    Packaging validation under ISO 11607-2 includes installation qualification of equipment, operational qualification to establish sealing parameter ranges, and performance qualification to demonstrate consistent production outcomes. It also requires package integrity testing (seal strength, burst, dye penetration), accelerated and real-time aging studies for shelf life validation, and distribution simulation testing.

    What documentation is required for ISO 11607 compliance?

    Required documentation includes: a design history file documenting the packaging design process and rationale, formal validation protocols with acceptance criteria defined before testing, validation reports recording test results and conclusions, material specifications and certificates of conformance, process control records for sealing and forming operations, and change control records for any modifications after initial validation.

    How do barrier pouches meet ISO 11607 requirements?

    Barrier pouches meet ISO 11607-1 requirements through their material properties, including microbial barrier, biocompatibility, and sterilization compatibility, and through the physical performance demonstrated in testing. Compliance with ISO 11607-2 is established through the sealing process validation program, which defines the acceptable parameter ranges and demonstrates consistent, repeatable seal performance within those ranges.

    Ready to Build Your ISO 11607 Compliance Program?

    Technipaq supports medical device manufacturers with ISO 11607-compliant barrier pouches, in-house testing capabilities, and ISO 13485-certified production. Contact the team at technipaq.com to discuss your sterile barrier system requirements and validation support needs.